TAMOXICAN 20 (Tamoxifen (20 mg))

Tamoxican 20 is formulated with Tamoxifen Citrate at a dosage of 20 mg, classified as a selective estrogen receptor modulator (SERM). This medication is primarily indicated for individuals diagnosed with hormone receptor-positive breast cancer. By effectively blocking the action of estrogen on breast tissues, Tamoxifen plays a vital role in impeding the progression of tumors that depend on estrogen for growth. Thus, it serves as a crucial element in the management of breast cancer. In addition to its therapeutic use, Tamoxican 20 is also employed as a preventive measure for breast cancer in individuals identified as high-risk. This preventive approach not only supports overall breast health but also aims to reduce the chances of cancer recurrence post-treatment. Tamoxifen is typically part of a comprehensive treatment regimen and requires careful monitoring due to potential side effects and interactions with other medications. Patients should be aware of its effects on the body and engage in regular conversations with their healthcare providers to ensure optimal outcomes through their cancer therapy. It is essential to follow the prescribed dosage and be vigilant about any developing symptoms or changes in health status. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.